D. E. Shaw & Co., Inc. Clearside Biomedical, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.0 - $6.12 $59,471 - $363,962	-59,471 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $358,610 - $668,454	59,471 New	59,471 $366,000
Q1 2018 May 15, 2018	SELL	$5.57 - $14.28 $73,139 - $187,510	-13,131 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.78 - $9.12 $75,897 - $119,754	13,131	13,131 $92,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $52.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.